BridgeMD
New treatment option for Depressive Disorder, Major
Official title Peer-led Intervention for Individuals With Major Depression.
ClinicalTrials.gov ID: NCT06398561
What this study is testing
- What it's testing
- Objective: To evaluate the efficacy of an adjuvant intervention based on a peer support program in the reduction of depressive symptomatology versus an online intervention in people with major depression in Primary Care Mental Health Units in Mallorca. Design: Randomized clinical trial of two branches in a Mental Health Unit of Mallorca, where one branch will receive an adjuvant intervention based on a peer support program (Active Patient Program) and another branch (control) will receive information and exercises aimed at improving their mental health through the COGITO App, designed and validated for this purpose.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Selection and withdrawal of people
- People over 18 years of age.
- Attending consultations with any of the professionals in the USM mental health network.
- Having an active diagnostic label of Major Depressive Disorder, according to ICD or DSM criteria in the Primary Care e-SIAP program or meeting MINI...
You likely can't join if
- People who present mental health disorders associated with a depressive disorder and who are in the acute phase of the disease.
- People who are not under active follow-up with any of the professionals of the USM.
- People with mobility problems and / or displacement to the health center.
- People suffering from another disease affecting the CNS (organic brain pathology or who have suffered a severe head injury, onset dementia or any...
- People with presence of uncontrolled serious medical, infectious or degenerative disease, which may interfere with affective symptomatology.
- People with significant risk of suicide according to medical criteria, assessed through follow-up interviews conducted by mental health professionals...
See the full eligibility criteria
- Selection and withdrawal of people
- People over 18 years of age.
- Attending consultations with any of the professionals in the USM mental health network.
- Having an active diagnostic label of Major Depressive Disorder, according to ICD or DSM criteria in the Primary Care e-SIAP program or meeting MINI TRAS criteria after individual interview for Major Depressive Episode.
- People who present mental health disorders associated with a depressive disorder and who are in the acute phase of the disease.
- People who are not under active follow-up with any of the professionals of the USM.
- People with mobility problems and / or displacement to the health center.
- People suffering from another disease affecting the CNS (organic brain pathology or who have suffered a severe head injury, onset dementia or any other neurodegenerative disease, etc.).
- People with presence of uncontrolled serious medical, infectious or degenerative disease, which may interfere with affective symptomatology.
- People with significant risk of suicide according to medical criteria, assessed through follow-up interviews conducted by mental health professionals of reference.
- People with any medical, psychological and/or social problem that could seriously interfere with the patient's participation in the study.
- People who are legally incapacitated to make health decisions.
The study team makes the final eligibility decision.
Where it's taking place
- Palma de Mallorca, Balearic Islands, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Palma de Mallorca, Balearic Islands, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.